搜索
scytek 价格更新
发布时间：2022-06-15
ScyTek Laboratories 成立于 1991 年，目标是成为为生命科学市场生产试剂的世界级制造公司。从早期为 OEM 市场生产 ELISA 试剂，ScyTek 逐渐扩大其生产能力，包括免疫组化试剂、特殊染色剂、常规染色剂、缓冲液、封固剂、固定剂、稀释剂和各种定制试剂。
ScyTek Laboratories 成立于 1991 年，目标是成为为生命科学市场生产试剂的世界级制造公司。从早期为 OEM 市场生产 ELISA 试剂，ScyTek 逐渐扩大其生产能力，包括免疫组化试剂、特殊染色剂、常规染色剂、缓冲液、封固剂、固定剂、稀释剂和各种定制试剂。
| scytek | MTF-20000 | Michel's Transport Fluid | 27249.12 |
| scytek | MTF500 | Michel's Transport Fluid | 2031.66 |
| scytek | MTF999 | Michel's Transport Fluid | 2232 |
| scytek | MTH3800 | Methanol | 3240 |
| scytek | MTH500 | Methanol | 2070 |
| scytek | MTH999 | Methanol | 2664 |
| scytek | MTM001 | Mouse to Mouse HRP (DAB) Staining System | 2772 |
| scytek | MTM002 | Mouse to Mouse HRP (AEC) Staining System | 2772 |
| scytek | MTM003 | Mouse to Mouse HRP Staining System | 7351.56 |
| scytek | MTM004 | Mouse to Mouse Alk-Phos (Fast Red) Staining System | 2772 |
| scytek | MTM005 | Mouse to Mouse Alk-Phos Staining System | 6318 |
| scytek | MTM008 | Mouse-to-Mouse Blocking Reagent | 1422 |
| scytek | MTM015 | Mouse-to-Mouse Blocking Reagent | 1822.14 |
| scytek | MTM125 | Mouse-to-Mouse Blocking Reagent | 6354 |
| scytek | MTM500 | Mouse-to-Mouse Blocking Reagent | 14436 |
| scytek | MTW-10000 | Michel's Transport Wash Buffer | 12348 |
| scytek | MTW-20000 | Michel's Transport Wash Buffer | 27990 |
| scytek | MTW500 | Michel's Transport Wash Buffer | 1746 |
| scytek | MTW999 | Michel's Transport Wash Buffer | 2232 |
| scytek | MYQ500 | Metanil Yellow (Aqueous Solution) | 2031.66 |
| scytek | MYQ999 | Metanil Yellow (Aqueous Solution) | 2597.22 |
| scytek | NF0001 | New Fuchsin Kit | 2106 |
| scytek | NF0002 | New Fuchsin Kit | 5801.76 |
| scytek | NFS3800 | Nuclear Fast Red Solution (Enhanced Stability) | 7236 |
| scytek | NFS500 | Nuclear Fast Red Solution (Enhanced Stability) | 2430 |
| scytek | NFS999 | Nuclear Fast Red Solution (Enhanced Stability) | 3812.04 |
| scytek | NFV500 | Newcomer's Fixative | 1494 |
| scytek | NFV999 | Newcomer's Fixative | 1962 |
| scytek | NPB125 | Naphthol Phosphate Buffer | 1566 |
| scytek | NPB500 | Naphthol Phosphate Buffer | 3114 |
| scytek | NPB999 | Naphthol Phosphate Buffer | 4140 |
| scytek | NPC125 | Naphthol Phosphate Buffer (High Contrast) | 1656 |
| scytek | NPC500 | Naphthol Phosphate Buffer (High Contrast) | 3042 |
| scytek | NPC999 | Naphthol Phosphate Buffer (High Contrast) | 3996 |
| scytek | NYS125 | Naphthol Yellow S Solution | 1800 |
| scytek | NYS500 | Naphthol Yellow S Solution | 3476.88 |
| scytek | NYS999 | Naphthol Yellow S Solution | 4248 |
| scytek | OAA125 | Orcein Solution | 1382.4 |
| scytek | OAA500 | Orcein Solution | 1926 |
| scytek | OAA999 | Orcein Solution | 2610 |
| scytek | OGA3800 | OG-6 Solution | 2412 |
| scytek | OGA500 | OG-6 Solution | 1242 |
| scytek | OGA999 | OG-6 Solution | 1512 |
| scytek | OQB125 | Oxalic Acid Solution (2.0%) | 1508.04 |
| scytek | OQB500 | Oxalic Acid Solution (2.0%) | 1620 |
| scytek | OQB999 | Oxalic Acid Solution (2.0%) | 2070 |
| scytek | ORG125 | Oil Red O Solution | 1350 |
| scytek | ORG500 | Oil Red O Solution | 2869.38 |
| scytek | ORG999 | Oil Red O Solution | 3798 |
| scytek | ORK-1 | Oil Red O Stain Kit (For Fat) | 3937.68 |
| scytek | ORK-2 | Oil Red O Stain Kit (For Fat) | 2160 |
| scytek | PAA125 | Periodic Acid Solution (0.5%) | 1508.04 |
| scytek | PAA500 | Periodic Acid Solution (0.5%) | 1746 |
| scytek | PAA999 | Periodic Acid Solution (0.5%) | 2556 |
| scytek | PAB125 | Picric Acid - Acetone Solution (0.1%) | 1350 |
| scytek | PAB500 | Picric Acid - Acetone Solution (0.1%) | 1602 |
| scytek | PAB999 | Picric Acid - Acetone Solution (0.1%) | 2345.76 |
| scytek | PAD-1 | Periodic Acid Schiff (PAS) Diastase Stain Kit | 3780 |
| scytek | PAD-2 | Periodic Acid Schiff (PAS) Diastase Stain Kit | 2322 |
| scytek | PAM008 | PolyTek, Anti-Mouse Polymerized HRP | 4140 |
| scytek | PAM015 | PolyTek, Anti-Mouse Polymerized HRP | 7875.18 |
| scytek | PAP-1 | Papanicolaou (PAP) Stain Kit | 2214 |
| scytek | PAP-2 | Papanicolaou (PAP) Stain Kit | 1566 |
| scytek | PAP-3 | Papanicolaou (PAP) Stain Kit | 4105.26 |
| scytek | PAQ030 | Periodic Acid Solution | 1188 |
| scytek | PAQ250 | Periodic Acid Solution | 1738.44 |
| scytek | PAQ500 | Periodic Acid Solution | 1926 |
| scytek | PAQ999 | Periodic Acid Solution | 2772 |
| scytek | PAS-2 | Periodic Acid Schiff (PAS) Stain Kit | 2157.3 |
| scytek | PAS-500 | Periodic Acid Schiff (PAS) Stain Kit | 3744 |
| scytek | PAV015 | Primary Antibody Dropper Vial | 954 |
| scytek | PBD010 | Phosphate Buffered Saline (10x) pH 7.4 | 4302 |
| scytek | PBD-20000 | Phosphate Buffered Saline (10x) pH 7.4 | 7650 |
| scytek | PBD500 | Phosphate Buffered Saline (10x) pH 7.4 | 1422 |
| scytek | PBD999 | Phosphate Buffered Saline (10x) pH 7.4 | 2031.66 |
| scytek | PBE010 | Phosphate Buffered Saline plus Tween 20 (10x) pH 7.4 | 4628.88 |
| scytek | PBE-20000 | Phosphate Buffered Saline plus Tween 20 (10x) pH 7.4 | 10962 |
| scytek | PBE500 | Phosphate Buffered Saline plus Tween 20 (10x) pH 7.4 | 1654.56 |
| scytek | PBE999 | Phosphate Buffered Saline plus Tween 20 (10x) pH 7.4 | 1746 |
| scytek | PBK010 | Pro-Block | 11826 |
| scytek | PBK125 | Pro-Block | 1314 |
| scytek | PBK-20000 | Pro-Block | 21150 |
| scytek | PBK500 | Pro-Block | 1800 |
| scytek | PBK999 | Pro-Block | 2178 |
| scytek | PBM500 | Phosphate Buffer Solution, pH 6.8 | 1296 |
| scytek | PBM999 | Phosphate Buffer Solution, pH 6.8 | 1512 |
| scytek | PBS010 | Phosphate Buffered Saline (25x) pH 7.6 | 4554 |
| scytek | PBS125 | Phosphate Buffered Saline (25x) pH 7.6 | 1098 |
| scytek | PBS-20000 | Phosphate Buffered Saline (25x) pH 7.6 | 12132 |
| scytek | PBS500 | Phosphate Buffered Saline (25x) pH 7.6 | 1466.1 |
| scytek | PBS999 | Phosphate Buffered Saline (25x) pH 7.6 | 1654.56 |
| scytek | PBT010 | Phosphate Buffered Saline plus Tween 20 (20x) pH 7.6 | 4628.88 |
| scytek | PBT-20000 | Phosphate Buffered Saline plus Tween 20 (20x) pH 7.6 | 7414.38 |
| scytek | PBT500 | Phosphate Buffered Saline plus Tween 20 (20x) pH 7.6 | 1466.1 |
| scytek | PBT999 | Phosphate Buffered Saline plus Tween 20 (20x) pH 7.6 | 1422 |
| scytek | PCS-1 | Pneumocystis Stain Kit | 2736 |
| scytek | PCS-2 | Pneumocystis Stain Kit | 2157.3 |
| scytek | PFB500 | Potassium Ferrocyanide Solution (5%) | 1494 |
| scytek | PFB999 | Potassium Ferrocyanide Solution (5%) | 1962 |
| scytek | PFD125 | Potassium Ferrocyanide Solution (3%) | 1296 |
| scytek | PFD500 | Potassium Ferrocyanide Solution (3%) | 1854 |
| scytek | PFD999 | Potassium Ferrocyanide Solution (3%) | 2995.02 |
| scytek | PGC250 | Phosphotungstic Acid Solution (5.0%) | 1854 |
| scytek | PGC500 | Phosphotungstic Acid Solution (5.0%) | 3058.02 |
| scytek | PGC999 | Phosphotungstic Acid Solution (5.0%) | 4922.1 |
| scytek | PHA500 | Potassium Hydroxide Solution (3M) | 1822.14 |
| scytek | PHA999 | Potassium Hydroxide Solution (3M) | 2124 |
| scytek | PHC500 | Potassium Hydroxide Solution (10%) | 1494 |
| scytek | PHC999 | Potassium Hydroxide Solution (10%) | 1998 |
| scytek | PIR080 | PolyTek HRP Anti-Mouse Polymerized Imaging System | 4554 |
| scytek | PMS125 | Potassium Metabisulfite Solution (3%) | 1296 |
| scytek | PMS500 | Potassium Metabisulfite Solution (3%) | 1800 |
| scytek | PMS999 | Potassium Metabisulfite Solution (3%) | 2974.14 |
| scytek | PMT030 | Permanent Mounting Media (Aqueous) | 2241.18 |
| scytek | PPA125 | Phosphomolybdic/Phosphotungstic Acid Solution | 1508.04 |
| scytek | PPA500 | Phosphomolybdic/Phosphotungstic Acid Solution | 2157.3 |
| scytek | PPA999 | Phosphomolybdic/Phosphotungstic Acid Solution | 2574 |
| scytek | PPD250 | Potassium Permanganate Solution (0.5%) | 1458 |
| scytek | PPD500 | Potassium Permanganate Solution (0.5%) | 2282.94 |
| scytek | PPD999 | Potassium Permanganate Solution (0.5%) | 2995.02 |
| scytek | PPE125 | Potassium Permanganate Solution (1.0%) | 1350 |
| scytek | PPE500 | Potassium Permanganate Solution (1.0%) | 1710 |
| scytek | PPE999 | Potassium Permanganate Solution (1.0%) | 2534.4 |
| scytek | PPG030 | Potassium Permanganate Solution (5%) | 1188 |
| scytek | PPG125 | Potassium Permanganate Solution (5%) | 1822.14 |
| scytek | PQA250 | Phosphomolybdic Acid Solution (0.2%) | 1062 |
| scytek | PQA500 | Phosphomolybdic Acid Solution (0.2%) | 1466.1 |
| scytek | PQA999 | Phosphomolybdic Acid Solution (0.2%) | 1548 |
| scytek | PRD-15 | Permanent Red Kit (For Alkaline Phosphatase) | 1602 |
| scytek | PRD-61 | Permanent Red Kit (For Alkaline Phosphatase) | 2358 |
| scytek | PRG500 | Propylene Glycol | 1566 |
| scytek | PSR-1 | Picro-Sirius Red Stain Kit (For Collagen) | 1818 |
| scytek | PSR-2 | Picro-Sirius Red Stain Kit (For Collagen) | 1591.74 |
| scytek | PSS060 | Pepsin, Stabilized Solution | 1926 |
| scytek | PSS125 | Pepsin, Stabilized Solution | 3162.6 |
| scytek | PTA-1 | PTAH Stain Kit for Microwave | 3749.04 |
| scytek | PTA-2 | PTAH Stain Kit for Microwave | 2070 |
| scytek | RA0001-C.1 | Actin, Smooth Muscle (Leiomyosarcoma Marker); Clone 1A4 (Concentrate) | 2576.16 |
| scytek | RA0001-C.5 | Actin, Smooth Muscle (Leiomyosarcoma Marker); Clone 1A4 (Concentrate) | 5256 |
| scytek | RA0002-C.1 | Actin, Smooth Muscle (Leiomyosarcoma Marker); Clone ACTA2/791 (Concentrate) | 2576.16 |
| scytek | RA0002-C.5 | Actin, Smooth Muscle (Leiomyosarcoma Marker); Clone ACTA2/791 (Concentrate) | 6115.86 |
| scytek | RA0003-C.1 | AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker); Clone C3 (Concentrate) | 2214 |
| scytek | RA0003-C.5 | AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker); Clone C3 (Concentrate) | 6115.86 |
| scytek | RA0004-C.1 | AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker); Clone FETA/810 (Concentrate) | 2214 |
| scytek | RA0004-C.5 | AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker); Clone FETA/810 (Concentrate) | 5256 |
| scytek | RA0005-C.1 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone ALP/870 (Concentrate) | 2214 |
| scytek | RA0005-C.5 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone ALP/870 (Concentrate) | 5256 |
| scytek | RA0006-C.1 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone GM022 (Concentrate) | 2214 |
| scytek | RA0006-C.5 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone GM022 (Concentrate) | 6115.86 |
| scytek | RA0007-C.1 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone PL8-F6 (Concentrate) | 2214 |
| scytek | RA0007-C.5 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone PL8-F6 (Concentrate) | 6115.86 |
| scytek | RA0008-C.1 | Prostate Specific Antigen (PSA); Clone A67-B/E3 (Concentrate) | 2214 |
| scytek | RA0008-C.5 | Prostate Specific Antigen (PSA); Clone A67-B/E3 (Concentrate) | 6115.86 |
| scytek | RA0009-C.1 | Prostate Specific Antigen (PSA); Clone KLK3/801 (Concentrate) | 2214 |
| scytek | RA0009-C.5 | Prostate Specific Antigen (PSA); Clone KLK3/801 (Concentrate) | 5256 |
| scytek | RA0010-C.1 | Androgen Receptor (Marker of Androgen Dependence); Clone AR441 (Concentrate) | 2576.16 |
| scytek | RA0010-C.5 | Androgen Receptor (Marker of Androgen Dependence); Clone AR441 (Concentrate) | 5256 |
| scytek | RA0011-C.1 | Androgen Receptor (Marker of Androgen Dependence); Clone DHTR/882 (Concentrate) | 2576.16 |
| scytek | RA0011-C.5 | Androgen Receptor (Marker of Androgen Dependence); Clone DHTR/882 (Concentrate) | 5256 |
| scytek | RA0012-C.1 | Androgen Receptor (Marker of Androgen Dependence); Clone AR441 & DHTR/882 (Concentrate) | 2214 |
| scytek | RA0012-C.5 | Androgen Receptor (Marker of Androgen Dependence); Clone AR441 & DHTR/882 (Concentrate) | 5256 |
| scytek | RA0013-C.1 | Bax (Apoptosis Marker); Clone 2D2 (Concentrate) | 2214 |
| scytek | RA0013-C.5 | Bax (Apoptosis Marker); Clone 2D2 (Concentrate) | 5256 |
| scytek | RA0014-C.1 | Cyclin D1 (G1-Cyclin & Mantle Cell Marker); Clone DCS-6 (Concentrate) | 2576.16 |
| scytek | RA0014-C.5 | Cyclin D1 (G1-Cyclin & Mantle Cell Marker); Clone DCS-6 (Concentrate) | 5256 |
| scytek | RA0015-C.1 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 100/D5 (Concentrate) | 2214 |
| scytek | RA0015-C.5 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 100/D5 (Concentrate) | 5256 |
| scytek | RA0016-C.1 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 124 (Concentrate) | 2214 |
| scytek | RA0016-C.5 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 124 (Concentrate) | 6115.86 |
| scytek | RA0017-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone 100/D5 & 124 (Concentrate) | 2576.16 |
| scytek | RA0017-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone 100/D5 & 124 (Concentrate) | 6115.86 |
| scytek | RA0018-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/782 (Concentrate) | 2214 |
| scytek | RA0018-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/782 (Concentrate) | 5256 |
| scytek | RA0019-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/796 (Concentrate) | 2214 |
| scytek | RA0019-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/796 (Concentrate) | 6115.86 |
| scytek | RA0020-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone 100/D5 & BCL2/796 | 2214 |
| scytek | RA0020-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone 100/D5 & BCL2/796 | 6115.86 |
| scytek | RA0021-C.1 | Bcl-X (Apoptosis Marker); Clone BX006 (Concentrate) | 2214 |
| scytek | RA0021-C.5 | Bcl-X (Apoptosis Marker); Clone BX006 (Concentrate) | 5256 |
| scytek | RA0022-C.1 | Bcl-X (Apoptosis Marker); Clone 2H12 (Concentrate) | 2214 |
| scytek | RA0022-C.5 | Bcl-X (Apoptosis Marker); Clone 2H12 (Concentrate) | 5256 |
| scytek | RA0023-C.1 | Bcl-X (Apoptosis Marker); Clone BX006 & 2H12 (Concentrate) | 2214 |
| scytek | RA0023-C.5 | Bcl-X (Apoptosis Marker); Clone BX006 & 2H12 (Concentrate) | 5256 |
| scytek | RA0024-C.1 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Concentrate) | 2576.16 |
| scytek | RA0024-C.5 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Concentrate) | 5256 |
| scytek | RA0025-C.1 | Complement 4d (C4d) (Acute Humoral Rejection Marker); Clone C4D204 (Concentrate) | 2576.16 |
| scytek | RA0025-C.5 | Complement 4d (C4d) (Acute Humoral Rejection Marker); Clone C4D204 (Concentrate) | 5256 |
| scytek | RA0026-C.1 | Renal Cell Carcinoma / gp200 (Carbonic Anhydrase IX); Clone 66.4.C2 (PN-15) (Concentrate) | 2576.16 |
| scytek | RA0026-C.5 | Renal Cell Carcinoma / gp200 (Carbonic Anhydrase IX); Clone 66.4.C2 (PN-15) (Concentrate) | 6115.86 |
| scytek | RA0027-C.1 | Renal Cell Carcinoma / gp200 (Carbonic Anhydrase IX); Clone CA9/781 (Concentrate) | 2214 |
| scytek | RA0027-C.5 | Renal Cell Carcinoma / gp200 (Carbonic Anhydrase IX); Clone CA9/781 (Concentrate) | 5256 |
| scytek | RA0028-C.1 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone h-CALD (Concentrate) | 2214 |
| scytek | RA0028-C.5 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone h-CALD (Concentrate) | 5256 |
| scytek | RA0029-C.1 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone CALD1/820 (Concentrate) | 2576.16 |
| scytek | RA0029-C.5 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone CALD1/820 (Concentrate) | 5256 |
| scytek | RA0030-C.1 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone CALD1/820 & h-CALD (Concentrate) | 2214 |
| scytek | RA0030-C.5 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone CALD1/820 & h-CALD (Concentrate) | 5256 |
| scytek | RA0031-C.1 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone O10 (Concentrate) | 2214 |
| scytek | RA0031-C.5 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone O10 (Concentrate) | 5256 |
| scytek | RA0032-C.1 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone C1A/711 (Concentrate) | 2576.16 |
| scytek | RA0032-C.5 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone C1A/711 (Concentrate) | 6115.86 |
| scytek | RA0033-C.1 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone O10 & C1A/711 (Concentrate) | 2576.16 |
| scytek | RA0033-C.5 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone O10 & C1A/711 (Concentrate) | 6115.86 |
| scytek | RA0034-C.1 | CD5 (Mantle Cell Lymphoma Marker); Clone C5/473 (Concentrate) | 2214 |
| scytek | RA0034-C.5 | CD5 (Mantle Cell Lymphoma Marker); Clone C5/473 (Concentrate) | 6115.86 |
| scytek | RA0036-C.1 | CD5 (Mantle Cell Lymphoma Marker); Clone CD5/54/F6 (Concentrate) | 2214 |
| scytek | RA0036-C.5 | CD5 (Mantle Cell Lymphoma Marker); Clone CD5/54/F6 (Concentrate) | 5256 |
| scytek | RA0037-C.1 | CD5 (Mantle Cell Lymphoma Marker); Clone C5/473 & CD5/54/F6 (Concentrate) | 2576.16 |
| scytek | RA0037-C.5 | CD5 (Mantle Cell Lymphoma Marker); Clone C5/473 & CD5/54/F6 (Concentrate) | 5256 |
| scytek | RA0038-C.1 | CD6; Clone 3F7B5 (Concentrate) | 2576.16 |
| scytek | RA0038-C.5 | CD6; Clone 3F7B5 (Concentrate) | 5256 |
| scytek | RA0039-C.1 | CD6; Clone C6/372 (Concentrate) | 2214 |
| scytek | RA0039-C.5 | CD6; Clone C6/372 (Concentrate) | 5256 |
| scytek | RA0040-C.1 | CD6; Clone C6/372 & 3F7B5 (Concentrate) | 2576.16 |
| scytek | RA0040-C.5 | CD6; Clone C6/372 & 3F7B5 (Concentrate) | 6115.86 |
| scytek | RA0041-C.1 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/468 (Concentrate) | 2576.16 |
| scytek | RA0041-C.5 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/468 (Concentrate) | 6115.86 |
| scytek | RA0042-C.1 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/144B (Concentrate) | 2214 |
| scytek | RA0042-C.5 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/144B (Concentrate) | 6115.86 |
| scytek | RA0043-C.1 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/468 & C8/144B (Concentrate) | 2576.16 |
| scytek | RA0043-C.5 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/468 & C8/144B (Concentrate) | 5256 |
| scytek | RA0044-C.1 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Rabbit Polyclonal (Concentrate) | 2214 |
| scytek | RA0044-C.5 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Rabbit Polyclonal (Concentrate) | 6115.86 |
| scytek | RA0045-C.1 | CD20 / MS4A1 (B-Cell Marker); Clone L26 (Concentrate) | 2214 |
| scytek | RA0045-C.5 | CD20 / MS4A1 (B-Cell Marker); Clone L26 (Concentrate) | 6115.86 |
| scytek | RA0046-C.1 | CD20 / MS4A1 (B-Cell Marker); Clone IGEL/773 (Concentrate) | 2214 |
| scytek | RA0046-C.5 | CD20 / MS4A1 (B-Cell Marker); Clone IGEL/773 (Concentrate) | 5256 |
| scytek | RA0047-C.1 | CD20 / MS4A1 (B-Cell Marker); Clone L26 & IGEL/773 (Concentrate) | 2576.16 |
| scytek | RA0047-C.5 | CD20 / MS4A1 (B-Cell Marker); Clone L26 & IGEL/773 (Concentrate) | 4338 |
| scytek | RA0048-C.1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone CD30/412 (Concentrate) | 2576.16 |
| scytek | RA0048-C.5 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone CD30/412 (Concentrate) | 5256 |
| scytek | RA0049-C.1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 (Concentrate) | 2214 |
| scytek | RA0049-C.5 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 (Concentrate) | 4338 |
| scytek | RA0049-C1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 (Concentrate) | 9069.12 |
| scytek | RA0050-C.1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ki-1/779 (Concentrate) | 2576.16 |
| scytek | RA0050-C.5 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ki-1/779 (Concentrate) | 5256 |
| scytek | RA0051-C.1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 & CD30/412 (Concentrate) | 2214 |
| scytek | RA0051-C.5 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 & CD30/412 (Concentrate) | 5047.74 |
| scytek | RA0052-C.1 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 (Concentrate) | 2576.16 |
| scytek | RA0052-C.5 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 (Concentrate) | 6115.86 |
| scytek | RA0053-C.1 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone HPCA1/763 (Concentrate) | 2576.16 |
| scytek | RA0053-C.5 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone HPCA1/763 (Concentrate) | 5256 |
| scytek | RA0054-C.1 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 & HPCA1/763 (Concentrate) | 2214 |
| scytek | RA0054-C.5 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 & HPCA1/763 (Concentrate) | 6115.86 |
| scytek | RA0055-C.1 | CD44 / HCAM Std.; Clone 156-3C11 (Concentrate) | 2214 |
| scytek | RA0056-C.1 | CD44 / HCAM Std.; Clone HCAM/918 (Concentrate) | 2214 |
| scytek | RA0055-C.5 | CD44 / HCAM Std.; Clone 156-3C11 (Concentrate) | 5256 |
| scytek | RA0056-C.5 | CD44 / HCAM Std.; Clone HCAM/918 (Concentrate) | 5256 |
| scytek | RA0057-C.1 | CD63 (Late Endosomes Marker); Clone NKI/C3 (Concentrate) | 2576.16 |
| scytek | RA0057-C.5 | CD63 (Late Endosomes Marker); Clone NKI/C3 (Concentrate) | 5256 |
| scytek | RA0058-C.1 | CD63 (Late Endosomes Marker); Clone MX-49.129.5 (Concentrate) | 2214 |
| scytek | RA0058-C.5 | CD63 (Late Endosomes Marker); Clone MX-49.129.5 (Concentrate) | 5256 |
| scytek | RA0059-C.1 | CD63 (Late Endosomes Marker); Clone LAMP3/803 (Concentrate) | 2214 |
| scytek | RA0059-C.5 | CD63 (Late Endosomes Marker); Clone LAMP3/803 (Concentrate) | 6115.86 |
| scytek | RA0060-C.1 | CD68 (Macrophage Marker); Clone KP1 (Concentrate) | 2214 |
| scytek | RA0060-C.5 | CD68 (Macrophage Marker); Clone KP1 (Concentrate) | 5256 |
| scytek | RA0061-C.1 | CD68 (Macrophage Marker); Clone C68/684 (Concentrate) | 2214 |
| scytek | RA0061-C.5 | CD68 (Macrophage Marker); Clone C68/684 (Concentrate) | 5256 |
| scytek | RA0062-C.1 | CD68 (Macrophage Marker); Clone KP1 & C68/684 (Concentrate) | 2214 |
| scytek | RA0062-C.5 | CD68 (Macrophage Marker); Clone KP1 & C68/684 (Concentrate) | 6115.86 |
| scytek | RA0063-C.1 | CD68 (Macrophage Marker); Clone LAMP4/824 (Concentrate) | 2214 |
| scytek | RA0063-C.5 | CD68 (Macrophage Marker); Clone LAMP4/824 (Concentrate) | 6115.86 |
| scytek | RA0064-C.1 | CD68 (Macrophage Marker); Clone CD68/G2 (Concentrate) | 2214 |
| scytek | RA0064-C.5 | CD68 (Macrophage Marker); Clone CD68/G2 (Concentrate) | 5256 |
| scytek | RA0065-C.1 | CD74 (B-Cell Marker); Clone LN-2 (Concentrate) | 2576.16 |
| scytek | RA0065-C.5 | CD74 (B-Cell Marker); Clone LN-2 (Concentrate) | 6115.86 |
| scytek | RA0066-C.1 | CD74 (B-Cell Marker); Clone CLIP/813 (Concentrate) | 2214 |
| scytek | RA0066-C.5 | CD74 (B-Cell Marker); Clone CLIP/813 (Concentrate) | 5256 |
| scytek | RA0067-C.1 | CD79a (B-Cell Marker); Clone JCB117 (Concentrate) | 2214 |
| scytek | RA0067-C.5 | CD79a (B-Cell Marker); Clone JCB117 (Concentrate) | 5256 |
| scytek | RA0069-C.1 | CD79a (B-Cell Marker); Clone HM47/A9 (Concentrate) | 2214 |
| scytek | RA0069-C.5 | CD79a (B-Cell Marker); Clone HM47/A9 (Concentrate) | 5256 |
| scytek | RA0071-C.1 | CD79a (B-Cell Marker); Clone JCB117 & HM47/A9 (Concentrate) | 2214 |
| scytek | RA0071-C.5 | CD79a (B-Cell Marker); Clone JCB117 & HM47/A9 (Concentrate) | 6115.86 |
| scytek | RA0072-C.1 | CD79a (B-Cell Marker); Clone IGA/764 (Concentrate) | 2214 |
| scytek | RA0072-C.5 | CD79a (B-Cell Marker); Clone IGA/764 (Concentrate) | 5256 |
| scytek | RA0073-C.1 | CD79a (B-Cell Marker); Clone IGA/515 (Concentrate) | 2214 |
| scytek | RA0073-C.5 | CD79a (B-Cell Marker); Clone IGA/515 (Concentrate) | 5256 |
| scytek | RA0074-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone WA-1 (HJ21) (Concentrate) | 2214 |
| scytek | RA0074-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone WA-1 (HJ21) (Concentrate) | 5256 |
| scytek | RA0075-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone DCS-60.2 (Concentrate) | 2576.16 |
| scytek | RA0075-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone DCS-60.2 (Concentrate) | 6115.86 |
| scytek | RA0076-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone CIP1/823 (Concentrate) | 2214 |
| scytek | RA0076-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone CIP1/823 (Concentrate) | 5256 |
| scytek | RA0077-C.1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone SX53G8 (Concentrate) | 2214 |
| scytek | RA0077-C.5 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone SX53G8 (Concentrate) | 5256 |
| scytek | RA0078-C.1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone KIP1/769 (Concentrate) | 2214 |
| scytek | RA0078-C.5 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone KIP1/769 (Concentrate) | 5256 |
| scytek | RA0079-C.1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone DCS-72.F6 (Concentrate) | 2576.16 |
| scytek | RA0079-C.5 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone DCS-72.F6 (Concentrate) | 5256 |
| scytek | RA0080-C.1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KP10 (Concentrate) | 2214 |
| scytek | RA0080-C.5 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KP10 (Concentrate) | 6115.86 |
| scytek | RA0081-C.1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KIP2/880 (Concentrate) | 2214 |
| scytek | RA0081-C.5 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KIP2/880 (Concentrate) | 6115.86 |
| scytek | RA0082-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone COL-1 (Concentrate) | 2214 |
| scytek | RA0082-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone COL-1 (Concentrate) | 5256 |
| scytek | RA0083-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/261 (Concentrate) | 2214 |
| scytek | RA0083-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/261 (Concentrate) | 6076.98 |
| scytek | RA0084-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone CEA31 (Concentrate) | 2576.16 |
| scytek | RA0084-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone CEA31 (Concentrate) | 5256 |
| scytek | RA0085-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone COL-1, CEA31 & C66/261 (Concentrate) | 2559.78 |
| scytek | RA0085-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone COL-1, CEA31 & C66/261 (Concentrate) | 5256 |
| scytek | RA0086-C.1 | hCG-alpha; Clone HCGa/53 (Concentrate) | 2576.16 |
| scytek | RA0086-C.5 | hCG-alpha; Clone HCGa/53 (Concentrate) | 5256 |
| scytek | RA0087-C.1 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/54 (Concentrate) | 2214 |
| scytek | RA0087-C.5 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/54 (Concentrate) | 5256 |
| scytek | RA0088-C.1 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/459 (Concentrate) | 2214 |
| scytek | RA0088-C.5 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/459 (Concentrate) | 5256 |
| scytek | RA0089-C.1 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/54 & HCGb/459 (Concentrate) | 2576.16 |
| scytek | RA0089-C.5 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/54 & HCGb/459 (Concentrate) | 5256 |
| scytek | RA0090-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CGA/414 (Concentrate) | 2576.16 |
| scytek | RA0090-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CGA/414 (Concentrate) | 5256 |
| scytek | RA0091-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10 (Concentrate) | 2214 |
| scytek | RA0091-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10 (Concentrate) | 6115.86 |
| scytek | RA0093-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone PHE5 (Concentrate) | 2214 |
| scytek | RA0093-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone PHE5 (Concentrate) | 5256 |
| scytek | RA0094-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10 & PHE5 (Concentrate) | 2214 |
| scytek | RA0094-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10 & PHE5 (Concentrate) | 6115.86 |
| scytek | RA0095-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10, PHE5 & CGA/414 (Concentrate) | 2214 |
| scytek | RA0095-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10, PHE5 & CGA/414 (Concentrate) | 6115.86 |
| scytek | RA0095-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10, PHE5 & CGA/414 (Concentrate) | 10933.2 |
| scytek | RA0096-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/765 (Concentrate) | 2576.16 |
| scytek | RA0096-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/765 (Concentrate) | 5256 |
| scytek | RA0097-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/777 (Concentrate) | 2214 |
| scytek | RA0097-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/777 (Concentrate) | 6115.86 |
| scytek | RA0098-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/798 (Concentrate) | 2214 |
| scytek | RA0098-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/798 (Concentrate) | 5256 |
| scytek | RA0099-C.1 | Calponin-1 (Smooth Muscle Marker); Clone CALP (Concentrate) | 2214 |
| scytek | RA0099-C.5 | Calponin-1 (Smooth Muscle Marker); Clone CALP (Concentrate) | 4338 |
| scytek | RA0100-C.1 | Calponin-1 (Smooth Muscle Marker); Clone CNN1/832 (Concentrate) | 2214 |
| scytek | RA0100-C.5 | Calponin-1 (Smooth Muscle Marker); Clone CNN1/832 (Concentrate) | 5047.74 |
| scytek | RA0101-C.1 | Calponin-1 (Smooth Muscle Marker); Clone CNN1/832 & CALP (Concentrate) | 2214 |
| scytek | RA0101-C.5 | Calponin-1 (Smooth Muscle Marker); Clone CNN1/832 & CALP (Concentrate) | 5047.74 |
| scytek | RA0102-C.1 | CD35 / CR1 (Follicular Dendritic Cell Marker); Clone E11 (Concentrate) | 2576.16 |
| scytek | RA0102-C.5 | CD35 / CR1 (Follicular Dendritic Cell Marker); Clone E11 (Concentrate) | 6115.86 |
| scytek | RA0103-C.1 | CD35 / CR1 (Follicular Dendritic Cell Marker); Clone CR1/802 (Concentrate) | 2214 |
| scytek | RA0103-C.5 | CD35 / CR1 (Follicular Dendritic Cell Marker); Clone CR1/802 (Concentrate) | 6115.86 |
| scytek | RA0104-C.1 | beta-Catenin (p120); Rabbit Polyclonal (Concentrate) | 2214 |
| scytek | RA0104-C.5 | beta-Catenin (p120); Rabbit Polyclonal (Concentrate) | 5256 |
| scytek | RA0105-C.1 | Secretory Component / ECM1; Clone SC05 (Concentrate) | 2214 |
| scytek | RA0105-C.5 | Secretory Component / ECM1; Clone SC05 (Concentrate) | 5256 |
| scytek | RA0106-C.1 | Secretory Component / ECM1; Clone ECM1/792 (Concentrate) | 2214 |
| scytek | RA0106-C.5 | Secretory Component / ECM1; Clone ECM1/792 (Concentrate) | 5256 |
| scytek | RA0107-C.1 | EGFR (Epidermal Growth Factor Receptor); Clone GFR450 (Concentrate) | 2214 |
| scytek | RA0107-C.5 | EGFR (Epidermal Growth Factor Receptor); Clone GFR450 (Concentrate) | 5256 |
| scytek | RA0108-C.1 | HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate) | 2576.16 |
| scytek | RA0108-C.5 | HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate) | 5256 |
| scytek | RA0109-C.1 | HER-2 / c-erbB-2 / neu / CD340; Clone ERB2/776 (Concentrate) | 2214 |
| scytek | RA0109-C.5 | HER-2 / c-erbB-2 / neu / CD340; Clone ERB2/776 (Concentrate) | 6115.86 |
| scytek | RA0110-C.1 | Estrogen Receptor (Marker of Estrogen Dependence); Clone ER505 (Concentrate) | 2559.78 |
| scytek | RA0110-C.5 | Estrogen Receptor (Marker of Estrogen Dependence); Clone ER505 (Concentrate) | 6076.98 |
| scytek | RA0111-C.1 | ER beta-1 (Estrogen Receptor beta-1); Clone ERb455 (Concentrate) | 2214 |
| scytek | RA0111-C.5 | ER beta-1 (Estrogen Receptor beta-1); Clone ERb455 (Concentrate) | 5256 |
| scytek | RA0112-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 (Concentrate) | 2214 |
| scytek | RA0112-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 (Concentrate) | 5256 |
| scytek | RA0113-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-9E3 (Concentrate) | 2559.78 |
| scytek | RA0113-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-9E3 (Concentrate) | 6115.86 |
| scytek | RA0114-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103 (Concentrate) | 2576.16 |
| scytek | RA0114-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103 (Concentrate) | 6076.98 |
| scytek | RA0115-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103, M2-7C10 & M2-9E3 (Concentrate) | 2214 |
| scytek | RA0115-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103, M2-7C10 & M2-9E3 (Concentrate) | 6076.98 |
| scytek | RA0116-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 & M2-9E3 (Concentrate) | 2214 |
| scytek | RA0116-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 & M2-9E3 (Concentrate) | 6076.98 |
| scytek | RA0117-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone DT101 & BC199 (Concentrate) | 2576.16 |
| scytek | RA0117-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone DT101 & BC199 (Concentrate) | 6115.86 |
| scytek | RA0118-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone MLANA/788 (Concentrate) | 2576.16 |
| scytek | RA0118-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone MLANA/788 (Concentrate) | 6076.98 |
| scytek | RA0119-C.1 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone Leu-M1 (MMA) (Concentrate) | 2576.16 |
| scytek | RA0119-C.5 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone Leu-M1 (MMA) (Concentrate) | 4338 |
| scytek | RA0119-C1 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone Leu-M1 (MMA) (Concentrate) | 10933.2 |
| scytek | RA0120-C.1 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone FUT4/815 (Concentrate) | 2214 |
| scytek | RA0120-C.5 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone FUT4/815 (Concentrate) | 4338 |
| scytek | RA0121-C.1 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone GA-5 (Concentrate) | 2576.16 |
| scytek | RA0121-C.5 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone GA-5 (Concentrate) | 5256 |
| scytek | RA0122-C.1 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone ASTRO/789 (Concentrate) | 2214 |
| scytek | RA0122-C.5 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone ASTRO/789 (Concentrate) | 5256 |
| scytek | RA0123-C.1 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone GA-5 & ASTRO/789 (Concentrate) | 2576.16 |
| scytek | RA0123-C.5 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone GA-5 & ASTRO/789 (Concentrate) | 5256 |
| scytek | RA0124-C.1 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone 1G12 (Concentrate) | 2576.16 |
| scytek | RA0124-C.5 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone 1G12 (Concentrate) | 5256 |
| scytek | RA0125-C.1 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone GPC3/863 (Concentrate) | 2214 |
| scytek | RA0125-C.5 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone GPC3/863 (Concentrate) | 5256 |
| scytek | RA0126-C.1 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone 1G12 & GPC3/863 (Concentrate) | 2576.16 |
| scytek | RA0126-C.5 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone 1G12 & GPC3/863 (Concentrate) | 5256 |
| scytek | RA0127-C.1 | GnRH-Receptor / LH-RH Receptor; Clone A9E4 (Concentrate) | 2576.16 |
| scytek | RA0127-C.5 | GnRH-Receptor / LH-RH Receptor; Clone A9E4 (Concentrate) | 4338 |
| scytek | RA0128-C.1 | GnRH-Receptor / LH-RH Receptor; Clone HH7/768 (Concentrate) | 2214 |
| scytek | RA0128-C.5 | GnRH-Receptor / LH-RH Receptor; Clone HH7/768 (Concentrate) | 5047.74 |
| scytek | RA0129-C.1 | Glycophorin A / CD235 (Erythrocyte Marker); Clone GPHN02 (Concentrate) | 2214 |
| scytek | RA0129-C.5 | Glycophorin A / CD235 (Erythrocyte Marker); Clone GPHN02 (Concentrate) | 5047.74 |
| scytek | RA0130-C.1 | Glycophorin A / CD235 (Erythrocyte Marker); Clone A63-B/C2 (Concentrate) | 2576.16 |
| scytek | RA0130-C.5 | Glycophorin A / CD235 (Erythrocyte Marker); Clone A63-B/C2 (Concentrate) | 4338 |
| scytek | RA0131-C.1 | HSP27 (Heat Shock Protein 27); Clone G3.1 (Concentrate) | 2214 |
| scytek | RA0131-C.5 | HSP27 (Heat Shock Protein 27); Clone G3.1 (Concentrate) | 5256 |
| scytek | RA0132-C.1 | HSP27 (Heat Shock Protein 27); Clone 24K/774 (Concentrate) | 2576.16 |
| scytek | RA0132-C.5 | HSP27 (Heat Shock Protein 27); Clone 24K/774 (Concentrate) | 5256 |
| scytek | RA0133-C.1 | HSP60 (Heat Shock Protein 60); Clone LK1 (Concentrate) | 2214 |
| scytek | RA0133-C.5 | HSP60 (Heat Shock Protein 60); Clone LK1 (Concentrate) | 5256 |
| scytek | RA0134-C.1 | HSP60 (Heat Shock Protein 60); Clone HLD4/780 (Concentrate) | 2576.16 |
| scytek | RA0134-C.5 | HSP60 (Heat Shock Protein 60); Clone HLD4/780 (Concentrate) | 5256 |
| scytek | RA0135-C.1 | Tenascin C (Stromal Marker For Epithelial Malignancy); Clone T2H5 (Concentrate) | 2214 |
| scytek | RA0135-C.5 | Tenascin C (Stromal Marker For Epithelial Malignancy); Clone T2H5 (Concentrate) | 4338 |
| scytek | RA0136-C.1 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone HISA3 (Concentrate) | 2214 |
| scytek | RA0136-C.5 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone HISA3 (Concentrate) | 5256 |
| scytek | RA0137-C.1 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone GA01 (Concentrate) | 2576.16 |
| scytek | RA0137-C.5 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone GA01 (Concentrate) | 5256 |
| scytek | RA0138-C.1 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone HISA3 & GA01 (Concentrate) | 2214 |
| scytek | RA0138-C.5 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone HISA3 & GA01 (Concentrate) | 5256 |
| scytek | RA0139-C.1 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG217 (Concentrate) | 2214 |
| scytek | RA0139-C.5 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG217 (Concentrate) | 5256 |
| scytek | RA0140-C.1 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG266 (Concentrate) | 2214 |
| scytek | RA0140-C.5 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG266 (Concentrate) | 6115.86 |
| scytek | RA0141-C.1 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG217 & IG266 (Concentrate) | 2214 |
| scytek | RA0141-C.5 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG217 & IG266 (Concentrate) | 6115.86 |
| scytek | RA0142-C.1 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone B33/20 (Concentrate) | 2214 |
| scytek | RA0142-C.5 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone B33/20 (Concentrate) | 5256 |
| scytek | RA0143-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone ICO-30 (Concentrate) | 2214 |
| scytek | RA0143-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone ICO-30 (Concentrate) | 6115.86 |
| scytek | RA0144-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone DA4-4 (SA-DA4 or HB57) (Concentrate) | 2214 |
| scytek | RA0144-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone DA4-4 (SA-DA4 or HB57) (Concentrate) | 6115.86 |
| scytek | RA0145-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM260 (Concentrate) | 2576.16 |
| scytek | RA0145-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM260 (Concentrate) | 6115.86 |
| scytek | RA0146-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM373 (Concentrate) | 2214 |
| scytek | RA0146-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM373 (Concentrate) | 5256 |
| scytek | RA0147-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM260 & ICO-30 (Concentrate) | 2214 |
| scytek | RA0147-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM260 & ICO-30 (Concentrate) | 6115.86 |
| scytek | RA0148-C.1 | Kappa Light Chain (B-Cell marker); Clone L1C1 (Concentrate) | 2214 |
| scytek | RA0148-C.5 | Kappa Light Chain (B-Cell marker); Clone L1C1 (Concentrate) | 5256 |
| scytek | RA0149-C.1 | Kappa Light Chain (B-Cell marker); Clone KLC264 (Concentrate) | 2214 |
| scytek | RA0149-C.5 | Kappa Light Chain (B-Cell marker); Clone KLC264 (Concentrate) | 5256 |
| scytek | RA0150-C.1 | Kappa Light Chain (B-Cell marker); Clone TB28-2 (Concentrate) | 2214 |
| scytek | RA0150-C.5 | Kappa Light Chain (B-Cell marker); Clone TB28-2 (Concentrate) | 6115.86 |
| scytek | RA0151-C.1 | Kappa Light Chain (B-Cell marker); Clone HP6053 (Concentrate) | 2576.16 |
| scytek | RA0152-C.1 | Kappa Light Chain (B-Cell marker); Clone HP6053 & L1C1 (Concentrate) | 2214 |
| scytek | RA0151-C.5 | Kappa Light Chain (B-Cell marker); Clone HP6053 (Concentrate) | 6115.86 |
| scytek | RA0152-C.5 | Kappa Light Chain (B-Cell marker); Clone HP6053 & L1C1 (Concentrate) | 6115.86 |
| scytek | RA0153-C.1 | Kappa Light Chain (B-Cell marker); Clone KLC709 (Concentrate) | 2214 |
| scytek | RA0153-C.5 | Kappa Light Chain (B-Cell marker); Clone KLC709 (Concentrate) | 5256 |
| scytek | RA0154-C.1 | Kappa Light Chain (B-Cell marker); Clone Kap-56 (Concentrate) | 2214 |
| scytek | RA0154-C.5 | Kappa Light Chain (B-Cell marker); Clone Kap-56 (Concentrate) | 6115.86 |
| scytek | RA0155-C.1 | Lambda Light Chain (B-Cell Marker); Clone ICO-106 (Concentrate) | 2576.16 |
| scytek | RA0155-C.5 | Lambda Light Chain (B-Cell Marker); Clone ICO-106 (Concentrate) | 5256 |
| scytek | RA0156-C.1 | Lambda Light Chain (B-Cell Marker); Clone HP6054 (Concentrate) | 2214 |
| scytek | RA0156-C.5 | Lambda Light Chain (B-Cell Marker); Clone HP6054 (Concentrate) | 5256 |
| scytek | RA0157-C.1 | Lambda Light Chain (B-Cell Marker); Clone LcN-2 (Concentrate) | 2214 |
| scytek | RA0157-C.5 | Lambda Light Chain (B-Cell Marker); Clone LcN-2 (Concentrate) | 5256 |
| scytek | RA0158-C.1 | Lambda Light Chain (B-Cell Marker); Clone LAM03 (Concentrate) | 2576.16 |
| scytek | RA0158-C.5 | Lambda Light Chain (B-Cell Marker); Clone LAM03 (Concentrate) | 5256 |
| scytek | RA0159-C.1 | Lambda Light Chain (B-Cell Marker); Clone LcN-2 & ICO-106 (Concentrate) | 2559.78 |
| scytek | RA0159-C.5 | Lambda Light Chain (B-Cell Marker); Clone LcN-2 & ICO-106 (Concentrate) | 5256 |
| scytek | RA0160-C.1 | Lambda Light Chain (B-Cell Marker); Clone Lamb14 (Concentrate) | 2214 |
| scytek | RA0160-C.5 | Lambda Light Chain (B-Cell Marker); Clone Lamb14 (Concentrate) | 6115.86 |
| scytek | RA0166-C.1 | Involucrin (Squamous Cell Terminal Differentiation Marker); Clone SY5 (Concentrate) | 2576.16 |
| scytek | RA0166-C.5 | Involucrin (Squamous Cell Terminal Differentiation Marker); Clone SY5 (Concentrate) | 6115.86 |
| scytek | RA0167-C.1 | Involucrin (Squamous Cell Terminal Differentiation Marker); Clone IVRN/827 (Concentrate) | 2214 |
| scytek | RA0167-C.5 | Involucrin (Squamous Cell Terminal Differentiation Marker); Clone IVRN/827 (Concentrate) | 5256 |
| scytek | RA0168-C.1 | CD117/c-Kit (Marker for Gastrointestinal Stromal Tumors); Clone C117/370 (Concentrate) | 2214 |
| scytek | RA0168-C.5 | CD117/c-Kit (Marker for Gastrointestinal Stromal Tumors); Clone C117/370 (Concentrate) | 5256 |
| scytek | RA0169-C.1 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone OV-TL12/30 (Concentrate) | 2576.16 |
| scytek | RA0169-C.5 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone OV-TL12/30 (Concentrate) | 6115.86 |
| scytek | RA0170-C.1 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone K72.7 (Concentrate) | 2214 |
| scytek | RA0170-C.5 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone K72.7 (Concentrate) | 6115.86 |
| scytek | RA0171-C.1 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone KRT7/760 (Concentrate) | 2214 |
| scytek | RA0171-C.5 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone KRT7/760 (Concentrate) | 5256 |
| scytek | RA0172-C.1 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone OV-TL12/30 & K72.7 (Concentrate) | 2576.16 |
| scytek | RA0172-C.5 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone OV-TL12/30 & K72.7 (Concentrate) | 5256 |
| scytek | RA0173-C.1 | Cytokeratin 8 (KRT8); Clone H1 (Concentrate) | 2576.16 |
| scytek | RA0173-C.5 | Cytokeratin 8 (KRT8); Clone H1 (Concentrate) | 6115.86 |
| scytek | RA0174-C.1 | Cytokeratin 8 (KRT8); Clone K8/383 (Concentrate) | 2214 |
| scytek | RA0174-C.5 | Cytokeratin 8 (KRT8); Clone K8/383 (Concentrate) | 5256 |
| scytek | RA0175-C.1 | Cytokeratin 8 (KRT8); Clone TS1 (Concentrate) | 2214 |
| scytek | RA0175-C.5 | Cytokeratin 8 (KRT8); Clone TS1 (Concentrate) | 5256 |
| scytek | RA0176-C.1 | Cytokeratin 8 (KRT8); Clone H1 & TS1 (Concentrate) | 2214 |
| scytek | RA0176-C.5 | Cytokeratin 8 (KRT8); Clone H1 & TS1 (Concentrate) | 6115.86 |
| scytek | RA0177-C.1 | Cytokeratin 8 (KRT8); Clone KRT8/818 (Concentrate) | 2214 |
| scytek | RA0177-C.5 | Cytokeratin 8 (KRT8); Clone KRT8/818 (Concentrate) | 5256 |
| scytek | RA0178-C.1 | Cytokeratin 8 (KRT8); Clone 34BH11 (Concentrate) | 2214 |
| scytek | RA0178-C.5 | Cytokeratin 8 (KRT8); Clone 34BH11 (Concentrate) | 5256 |
| scytek | RA0179-C.1 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone AE20 (Concentrate) | 2576.16 |
| scytek | RA0179-C.5 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone AE20 (Concentrate) | 5256 |
| scytek | RA0180-C.1 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone KRT10/844 (Concentrate) | 2576.16 |
| scytek | RA0180-C.5 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone KRT10/844 (Concentrate) | 5256 |
| scytek | RA0181-C.1 | Cytokeratin 14 (KRT14) (Squamous Cell Marker); Clone LL002 (Concentrate) | 2214 |
| scytek | RA0181-C.5 | Cytokeratin 14 (KRT14) (Squamous Cell Marker); Clone LL002 (Concentrate) | 5256 |
| scytek | RA0182-C.1 | Cytokeratin 17 (KRT17) (Basal Epithelial Marker); Clone E3 (Ks17.E3) (Concentrate) | 2576.16 |
| scytek | RA0182-C.5 | Cytokeratin 17 (KRT17) (Basal Epithelial Marker); Clone E3 (Ks17.E3) (Concentrate) | 6115.86 |
| scytek | RA0183-C.1 | Cytokeratin 17 (KRT17) (Basal Epithelial Marker); Clone KRT17/778 (Concentrate) | 2214 |
| scytek | RA0183-C.5 | Cytokeratin 17 (KRT17) (Basal Epithelial Marker); Clone KRT17/778 (Concentrate) | 6115.86 |
| scytek | RA0184-C.1 | Cytokeratin 18 (KRT18); Clone DC10 (Concentrate) | 2576.16 |
| scytek | RA0184-C.5 | Cytokeratin 18 (KRT18); Clone DC10 (Concentrate) | 5256 |
| scytek | RA0185-C.1 | Cytokeratin 18 (KRT18); Clone DA7 (Concentrate) | 2576.16 |
| scytek | RA0185-C.5 | Cytokeratin 18 (KRT18); Clone DA7 (Concentrate) | 6115.86 |
| scytek | RA0186-C.1 | Cytokeratin 18 (KRT18); Clone DE-K18 (Concentrate) | 2214 |
| scytek | RA0186-C.5 | Cytokeratin 18 (KRT18); Clone DE-K18 (Concentrate) | 6115.86 |
| scytek | RA0187-C.1 | Cytokeratin 18 (KRT18); Clone KRT18/834 (Concentrate) | 2214 |
| scytek | RA0187-C.5 | Cytokeratin 18 (KRT18); Clone KRT18/834 (Concentrate) | 6115.86 |
| scytek | RA0188-C.1 | Cytokeratin 18 (KRT18); Clone KRT18/835 (Concentrate) | 2576.16 |
| scytek | RA0188-C.5 | Cytokeratin 18 (KRT18); Clone KRT18/835 (Concentrate) | 5256 |
| scytek | RA0189-C.1 | Cytokeratin 18 (KRT18); Clone KRT18/836 (Concentrate) | 2214 |
| scytek | RA0189-C.5 | Cytokeratin 18 (KRT18); Clone KRT18/836 (Concentrate) | 5256 |
| scytek | RA0190-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone A53-B/A2.26 (Ks19.1) (Concentrate) | 2214 |
| scytek | RA0190-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone A53-B/A2.26 (Ks19.1) (Concentrate) | 5256 |
| scytek | RA0191-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone BA17 (Concentrate) | 2214 |
| scytek | RA0191-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone BA17 (Concentrate) | 6115.86 |
| scytek | RA0192-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone A53-B/A2.26 & BA17 (Concentrate) | 2214 |
| scytek | RA0192-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone A53-B/A2.26 & BA17 (Concentrate) | 6115.86 |
| scytek | RA0193-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/799 (Concentrate) | 2214 |
| scytek | RA0193-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/799 (Concentrate) | 5256 |
| scytek | RA0194-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/800 (Concentrate) | 2214 |
| scytek | RA0194-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/800 (Concentrate) | 5256 |
| scytek | RA0195-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone VU-1D9 (Concentrate) | 2214 |
| scytek | RA0195-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone VU-1D9 (Concentrate) | 5256 |
| scytek | RA0196-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone MOC-31 (Concentrate) | 2576.16 |
| scytek | RA0196-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone MOC-31 (Concentrate) | 5047.74 |
| scytek | RA0197-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone Ber-EP4 (Concentrate) | 2214 |
| scytek | RA0197-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone Ber-EP4 (Concentrate) | 4338 |
| scytek | RA0198-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone HEA125 (Concentrate) | 2214 |
| scytek | RA0198-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone HEA125 (Concentrate) | 6115.86 |
| scytek | RA0199-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone EGP40/826 (Concentrate) | 2576.16 |
| scytek | RA0199-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone EGP40/826 (Concentrate) | 5256 |
| scytek | RA0200-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone EGP40/837 (Concentrate) | 2214 |
| scytek | RA0200-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone EGP40/837 (Concentrate) | 6115.86 |
| scytek | RA0201-C.1 | MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate) | 2576.16 |
| scytek | RA0201-C.5 | MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Concentrate) | 6115.86 |
| scytek | RA0202-C.1 | MAGE-1 (Target for Cancer Immunotherapy); Clone MZ2E/838 (Concentrate) | 2576.16 |
| scytek | RA0202-C.5 | MAGE-1 (Target for Cancer Immunotherapy); Clone MZ2E/838 (Concentrate) | 5256 |
| scytek | RA0203-C.1 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone HO36-1.1 (Concentrate) | 2214 |
| scytek | RA0203-C.5 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone HO36-1.1 (Concentrate) | 4338 |
| scytek | RA0204-C.1 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone 12E7 (Concentrate) | 2576.16 |
| scytek | RA0204-C.5 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone 12E7 (Concentrate) | 4338 |
| scytek | RA0205-C.1 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone MIC2/877 (Concentrate) | 2214 |
| scytek | RA0205-C.5 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone MIC2/877 (Concentrate) | 6115.86 |
| scytek | RA0206-C.1 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone 12E7 & MIC2/877 (Concentrate) | 2576.16 |
| scytek | RA0206-C.5 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone 12E7 & MIC2/877 (Concentrate) | 5047.74 |
| scytek | RA0207-C.1 | Microphthalmia Transcription Factor (MITF); Clone D5 (Concentrate) | 2576.16 |
| scytek | RA0207-C.5 | Microphthalmia Transcription Factor (MITF); Clone D5 (Concentrate) | 5256 |
| scytek | RA0208-C.1 | Microphthalmia Transcription Factor (MITF); Clone MITF/915 (Concentrate) | 2214 |
| scytek | RA0208-C.5 | Microphthalmia Transcription Factor (MITF); Clone MITF/915 (Concentrate) | 5256 |
| scytek | RA0210-C.1 | Microphthalmia Transcription Factor (MITF); Clone D5 & MITF/915 (Concentrate) | 2214 |
| scytek | RA0210-C.5 | Microphthalmia Transcription Factor (MITF); Clone D5 & MITF/915 (Concentrate) | 5256 |
| scytek | RA0211-C.1 | Moesin; Clone MSN491 (Concentrate) | 2214 |
| scytek | RA0211-C.5 | Moesin; Clone MSN491 (Concentrate) | 5256 |
| scytek | RA0212-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone GP1.4 (Concentrate) | 2214 |
| scytek | RA0212-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone GP1.4 (Concentrate) | 6115.86 |
| scytek | RA0214-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone E29 (Concentrate) | 2214 |
| scytek | RA0214-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone E29 (Concentrate) | 6115.86 |
| scytek | RA0215-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone GP1.4 & E29 (Concentrate) | 2576.16 |
| scytek | RA0215-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone GP1.4 & E29 (Concentrate) | 5256 |
| scytek | RA0216-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone PEM/845 (Concentrate) | 2576.16 |
| scytek | RA0216-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone PEM/845 (Concentrate) | 6115.86 |
| scytek | RA0217-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone 139H2 (Concentrate) | 2559.78 |
| scytek | RA0217-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone 139H2 (Concentrate) | 6115.86 |
| scytek | RA0218-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone HMPV (Concentrate) | 2576.16 |
| scytek | RA0218-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone HMPV (Concentrate) | 5256 |
| scytek | RA0219-C.1 | MUC2 (Mucin 2); Clone CCP58 (Concentrate) | 2214 |
| scytek | RA0219-C.5 | MUC2 (Mucin 2); Clone CCP58 (Concentrate) | 5256 |
| scytek | RA0220-C.1 | MUC2 (Mucin 2); Clone MLP/842 (Concentrate) | 2214 |
| scytek | RA0220-C.5 | MUC2 (Mucin 2); Clone MLP/842 (Concentrate) | 5256 |
| scytek | RA0221-C.1 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone 45M1 (Concentrate) | 2214 |
| scytek | RA0221-C.5 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone 45M1 (Concentrate) | 5256 |
| scytek | RA0222-C.1 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone CLH2 (Concentrate) | 2576.16 |
| scytek | RA0222-C.5 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone CLH2 (Concentrate) | 5256 |
| scytek | RA0223-C.1 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone MUC5AC/917 (Concentrate) | 2214 |
| scytek | RA0223-C.5 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone MUC5AC/917 (Concentrate) | 5256 |
| scytek | RA0224-C.1 | MUC6 (Mucin 6 / Gastric Mucin); Clone CLH5 (Concentrate) | 2214 |
| scytek | RA0224-C.5 | MUC6 (Mucin 6 / Gastric Mucin); Clone CLH5 (Concentrate) | 5256 |
| scytek | RA0225-C.1 | MUC6 (Mucin 6 / Gastric Mucin); Clone MUC6/916 (Concentrate) | 2214 |
| scytek | RA0225-C.5 | MUC6 (Mucin 6 / Gastric Mucin); Clone MUC6/916 (Concentrate) | 5256 |
| scytek | RA0226-C.1 | c-Myc Oncoprotein; Clone 9E10.3 (Concentrate) | 2214 |
| scytek | RA0226-C.5 | c-Myc Oncoprotein; Clone 9E10.3 (Concentrate) | 5256 |
| scytek | RA0227-C.1 | c-Myc Oncoprotein; Clone MYC909 (Concentrate) | 2576.16 |
| scytek | RA0227-C.5 | c-Myc Oncoprotein; Clone MYC909 (Concentrate) | 5256 |
| scytek | RA0228-C.1 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone SMMS-1 (Concentrate) | 2214 |
| scytek | RA0228-C.5 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone SMMS-1 (Concentrate) | 5256 |
| scytek | RA0229-C.1 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone ID8 (Concentrate) | 2576.16 |
| scytek | RA0229-C.5 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone ID8 (Concentrate) | 6115.86 |
| scytek | RA0230-C.1 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone MYH11/923 (Concentrate) | 2576.16 |
| scytek | RA0230-C.5 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone MYH11/923 (Concentrate) | 6115.86 |
| scytek | RA0231-C.1 | MyoD1 (Rhabdomyosarcoma Marker); Clone 5.8A (Concentrate) | 2214 |
| scytek | RA0231-C.5 | MyoD1 (Rhabdomyosarcoma Marker); Clone 5.8A (Concentrate) | 5256 |
| scytek | RA0232-C.1 | MyoD1 (Rhabdomyosarcoma Marker); Clone MYD712 (Concentrate) | 2214 |
| scytek | RA0232-C.5 | MyoD1 (Rhabdomyosarcoma Marker); Clone MYD712 (Concentrate) | 5256 |
| scytek | RA0233-C.1 | MyoD1 (Rhabdomyosarcoma Marker); Clone 5.8A & MYD712 (Concentrate) | 2214 |
| scytek | RA0233-C.5 | MyoD1 (Rhabdomyosarcoma Marker); Clone 5.8A & MYD712 (Concentrate) | 6115.86 |
| scytek | RA0234-C.1 | Myogenin (Skeletal Muscle Marker); Clone MGN185 (Concentrate) | 2214 |
| scytek | RA0234-C.5 | Myogenin (Skeletal Muscle Marker); Clone MGN185 (Concentrate) | 6115.86 |
| scytek | RA0235-C.1 | Myogenin (Skeletal Muscle Marker); Clone F5D (Concentrate) | 2214 |
| scytek | RA0235-C.5 | Myogenin (Skeletal Muscle Marker); Clone F5D (Concentrate) | 5256 |
| scytek | RA0236-C.1 | Myogenin (Skeletal Muscle Marker); Clone MGN185 & F5D (Concentrate) | 2214 |
| scytek | RA0236-C.5 | Myogenin (Skeletal Muscle Marker); Clone MGN185 & F5D (Concentrate) | 6115.86 |
| scytek | RA0237-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123C3.D5 (Concentrate) | 2576.16 |
| scytek | RA0237-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123C3.D5 (Concentrate) | 6115.86 |
| scytek | RA0238-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123A8 (56C04) (Concentrate) | 2576.16 |
| scytek | RA0238-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123A8 (56C04) (Concentrate) | 5256 |
| scytek | RA0239-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123C3.D5 & 123A8 (Concentrate) | 2214 |
| scytek | RA0239-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123C3.D5 & 123A8 (Concentrate) | 5256 |
| scytek | RA0240-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone NKH1/784 (Concentrate) | 2576.16 |
| scytek | RA0240-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone NKH1/784 (Concentrate) | 5256 |
| scytek | RA0241-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone NKH1/795 (Concentrate) | 2214 |
| scytek | RA0241-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone NKH1/795 (Concentrate) | 5256 |
无锡药科美生物科技有限公司专业从事生命科学行业前沿技术服务与产品进出口服务，欢迎订购咨询全球各国各种进口产品。
上一篇：
scytek 价格更新
下一篇：
scytek 价格更新
